| Ashley Dawn Legassie, LMSW-CC | |
|
1 Edgemont Dr, Presque Isle, ME 04769-2036 | |
| (207) 764-3319 | |
| (207) 768-5377 |
| Full Name | Ashley Dawn Legassie |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1 Edgemont Dr, Presque Isle, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275981672 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | MC15539 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Dawn Legassie, LMSW-CC 647 Main St Ste 14b, Caribou, ME 04736-4509 Ph: (207) 492-3009 | Ashley Dawn Legassie, LMSW-CC 1 Edgemont Dr, Presque Isle, ME 04769-2036 Ph: (207) 764-3319 |
News Archive
A number of studies have shown that excess insulin circulating in the bloodstream is a major independent risk factor for cardiovascular disease. However, a new study from Joslin Diabetes Center finds that this condition, called hyperinsulinemia, is itself not a cause of atherosclerosis.
Obamacare programs designed to help people are running into problems concerning how much money people have when they get covered.
Cascade Technologies Corp. announced today that it has entered into a non-binding letter of intent to acquire all of the assets of AcuNetx, Inc., a Nevada corporation in exchange for common stock of Cascade.
Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration approved Epaned for the treatment of symptomatic heart failure and the treatment of asymptomatic left ventricular dysfunction (to decrease the rate of development of overt heart failure and to reduce hospitalization for heart failure).
Dose-limiting anemia can be a prominent adverse event of therapy with pegylated interferon and ribavirin. This dose-ranging study examined whether viramidine, a liver-targeting prodrug of ribavirin, may be a safer alternative when used in combination with pegylated interferon alfa-2a/ PEG-IFN (Pegasys).
› Verified 2 days ago
Trisha M. Stubbs, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 45 Hillside St, Presque Isle, ME 04769 Phone: 207-768-0368 Fax: 207-764-1649 | |
Ralph B Mcpherson, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 140 Academy St, Presque Isle, ME 04769 Phone: 207-768-4256 Fax: 207-768-4048 | |
Mrs. Linda M Chalou, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 147 Academy Street, Presque Isle, ME 04769 Phone: 207-764-6825 Fax: 207-764-6077 | |
Mrs. Penney A. Siddiqui, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 169 Academy St, Presque Isle, ME 04769 Phone: 207-551-1274 | |
Georgette A Beaulieu, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 421 Main St, Presque Isle, ME 04769 Phone: 207-764-8573 | |
Christina Wall, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 162 Main St, Presque Isle, ME 04769 Phone: 207-768-3304 Fax: 207-540-1350 | |
Mr. Christopher Stephen Morse, MSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 19 Houlton Rd, Presque Isle, ME 04769 Phone: 207-764-3071 Fax: 207-764-3659 |